BioSpace News Archive

Carrick Therapeutics today announces two presentations at the 2021 San Antonio Breast Cancer Symposium (SABCS), to be held from December 7-10, 2021.

At the opening ceremony of the 4th China International Import Expo (CIIE) held in Shanghai on November 6, 2021, SYZJ001, a bispecific antibody drug against COVID-19 jointly developed by Shanghai ZJ Bio-Tech Co., Ltd. and Sanyou Biopharmaceuticals (Shanghai) Co., Ltd., made a brilliant appearance.

ASA, The Bladder Cancer Company, announces that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer, Erik Dahl will present a corporate overview and host 1-on-1 meetings with investors at the Piper Sandler 33rd Annual Healthcare conference, being held virtually November 29 through December 2, 2021.

Intrauterine contraceptive devices appear to have systemic effects on the body like those of hormone replacement therapy, according to a breast MRI study being presented next week at the annual meeting of the Radiological Society of North America.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, provided an overview of its innovative pipeline with a focus on five mid- to late-stage assets with first-in-class and/or best-in-class potential at its R&D Update Call.

Notable Labs, Inc., a clinical-stage platform therapeutics company, announced two abstracts have been accepted for poster presentation at the 63rd American Society of Hematology Annual Meeting and Exposition.

Amphastar Pharmaceuticals, Inc. announced that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. Corporate Administration Center and Sales & Marketing, participated in an Analyst-Moderated fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Pfizer Inc. and BioNTech SE announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that company management will participate in virtual 1x1 investor meetings at the Piper Sandler 33rd Annual Healthcare Conference taking place November 29, 2021 through December 2, 2021.

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, will participate in a virtual fireside chat at the 4th Annual Evercore ISI HealthCONx Conference on Wednesday, December 1, 2021 at 3:05 p.m. ET.